Vinculin activators represent a diverse category of chemical compounds with multifaceted impacts on vinculin activation, operating through intricate cellular pathways. This expansive group encompasses an array of chemicals, including myosin inhibitors and small GTPase modulators, each playing pivotal roles in the regulation of vinculin-mediated cellular adhesion and migration. One notable example is Calyculin A, a potent protein phosphatase inhibitor. This compound directly activates vinculin by promoting sustained phosphorylation of key residues, thereby enhancing focal adhesion dynamics and augmenting cell-matrix interactions. Similarly, Blebbistatin, classified as a myosin II ATPase inhibitor, indirectly activates vinculin by mitigating actomyosin contractility.
This mechanism facilitates vinculin binding and clustering at both cell-cell and cell-matrix junctions, ultimately influencing cellular adhesion and migration processes. Another noteworthy vinculin activator is SMIFH2, recognized as a formin inhibitor. This chemical modulates actin dynamics, resulting in the formation of stable focal adhesions and reinforcing vinculin-mediated cell-substrate adhesion. The impact of vinculin activation extends to the regulation of Rho GTPases, exemplified by NSC23766, a Rac1 inhibitor. This compound indirectly activates vinculin by modulating Rac1-mediated actin remodeling, thereby influencing cytoskeletal dynamics and intracellular signaling cascades.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatase 1 and 2A. It activates vinculin by promoting the phosphorylation of key residues through sustained kinase activity, leading to enhanced focal adhesion dynamics and cell-matrix interactions. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide is a stabilizer of actin filaments. It activates vinculin by enhancing actin polymerization, leading to the formation of robust focal adhesions and increased cellular traction forces. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A disrupts actin polymerization by sequestering G-actin monomers. This indirect activator of vinculin influences cytoskeletal organization, leading to reduced stress fiber formation and increased focal adhesion turnover, promoting vinculin recruitment and activation at cell-matrix junctions. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that elevates intracellular calcium levels. It activates vinculin through calcium-dependent signaling pathways, promoting its association with focal adhesions and reinforcing cell-substrate interactions. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
SMIFH2 is a formin inhibitor that disrupts actin filament elongation. It indirectly activates vinculin by altering actin cytoskeleton dynamics, leading to the formation of stable focal adhesions. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is a myosin light chain kinase (MLCK) inhibitor. It indirectly activates vinculin by modulating actomyosin contractility, promoting the stabilization of focal adhesions. | ||||||